Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-RIP kinase-SIR1-365
SIR1-365

Chemical Structure : SIR1-365

CAS No.: 2428422-17-5

SIR1-365

Catalog No.: PC-24511Not For Human Use, Lab Use Only.

SIR1-365 is a highly potent, selective, and metabolically stable allosteric kinase inhibitor of RIPK1.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

SIR1-365 is a highly potent, selective, and metabolically stable allosteric kinase inhibitor of RIPK1.
SIR1-365 efficiently reduces TNF-α-induced mortality and multiorgan damage in systemic inflammatory response syndrome mice disease model.
SIR1-365 significantly increased arterial oxygenation from baseline in hospitalized patients with severe COVID-19.

Physicochemical Properties

M.Wt 257.28
Formula C13H17F2NO2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(3,5-difluorobenzyl)-N-hydroxy-2,2-dimethylbutanamide

References

1. Chavez-Tapia N, et al. J Intensive Med. 2024 Sep 12;5(1):70-78.

2. Alba GA, et al. EClinicalMedicine. 2021 Aug 28;39:101066.

3. Yan Ren, et al. J Med Chem. 2017 Feb 9;60(3):972-986.

4. Patent WO 2020103859.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: